Geoffroy Vanbiervliet

BACKGROUND: Biological treatment in inflammatory bowel disease (IBD) patients is currently hampered by high non-response rates. To enhance personalized medicine and predict response to biological therapeutics such as vedolizumab, the working mechanism should be elucidated…

Severe gastroparesis (GP) is one of the major complications occurring in 15 to 40% of patients after esophagectomy with gastric pull-through despite recent progress in surgical techniques. GP significantly impacts the patients’ quality of life and nutritional status…

Background: The adoption of endoscopic submucosal dissection (ESD) as the main option for large colorectal lesions is still limited in the West. A recent high-quality study showed colorectal ESD has been proved equally safe and more effective than piecemeal endoscopic mucosal resection (EMR)…

Missed lesions are common during standard colonoscopy and are correlated with post-colonoscopy colorectal cancer (PCCRC). Contrast enhanced technologies have recently been developed to improve polyp detection…